Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Probably Genetic raises $12M to scale rare disease dataset, support drug discovery

The company’s core product is a physician-ordered genetic test for undiagnosed rare disease patients, who typically face a seven-year diagnostic odyssey before getting answers.

We haven't written up this one. Fierce Healthcare has the full story — the link below goes straight to it.

Read the original at fiercehealthcare.com →

More in Health & Medicine

More from Wednesday 14 October →